Clinical Trials Browser

Observational × Hypersensitivity × 90 days × Clear all

Carcinoma, Carcinoma, Basal Cell, Eyelid Diseases, Eyelid Neoplasms, Hypersensitivity, Neoplasms, Glandular and Epithelial, Recurrence, Skin Diseases, Skin Neoplasms

NCT07572162 2026-05-07

Post-market Safety Study of LUMISIGHT

Not yet recruiting

1,500 enrolled

Breast

Anaphylaxis, Breast Neoplasms, Drug Hypersensitivity, Hypersensitivity

NCT07511517 2026-04-09

BladMetrix

Active not recruiting

500 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma, Hypersensitivity

Clinical Trials

dOCT-pBCC

Post-market Safety Study of LUMISIGHT

BladMetrix